Skip to main content
. 2018 Mar 13;2(5):nzy013. doi: 10.1093/cdn/nzy013

TABLE 2.

IC50 values in HeLa cells cultured for 96–120 h with 50 µM deoxyuridine or 50 µM uridine1

IC50 relative to control (no nucleosides)
Treatment 50 µM uridine 50 µM deoxyuridine P (comparison between nucleotide treatments)
5-Fluorouracil 1.30 ± 0.18 0.77 ± 0.20 P < 0.01
Methotrexate 1.16 ± 0.12 0.85 ± 0.26 P = 0.03
1

Values are means ± SDs of the normalized ratio of 4 independent experiments. IC50 curves were generated by using 0.1–1000 µM 5-fluorouracil and 0.001–0.5 µM methotrexate; viability was measured by using the MTT assay. IC50 values for each treatment were normalized to IC50 of control (no nucleoside supplementation). IC50, concentration of an inhibitor where the response is reduced by half; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.